Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Metoprolol

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Metoprolol

Jason Morris et al.
Free Books & Documents

Excerpt

Metoprolol, a widely employed β-adrenergic antagonist, is pivotal in cardiovascular pharmacology. Metoprolol is indicated primarily for conditions such as hypertension, angina pectoris, heart failure, and arrhythmias. The medication exerts its therapeutic effect by selectively inhibiting β-1 adrenergic receptors, resulting in diminished cardiac contractility, heart rate, and blood pressure. While generally well-tolerated, metoprolol may elicit adverse effects, including bradycardia, hypotension, and bronchospasm, necessitating vigilant patient monitoring. Contraindications encompass conditions such as severe bradycardia, heart block, and decompensated heart failure, warranting cautious use of alternative therapies. An adept understanding of metoprolol's multifaceted clinical profile empowers healthcare professionals to navigate treatment decisions judiciously, promoting favorable patient outcomes in cardiovascular management.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Jason Morris declares no relevant financial relationships with ineligible companies.

Disclosure: Ayoola Awosika declares no relevant financial relationships with ineligible companies.

Disclosure: Alexis Dunham declares no relevant financial relationships with ineligible companies.

References

    1. Papadopoulos DP, Papademetriou V. Metoprolol succinate combination in the treatment of hypertension. Angiology. 2009 Oct-Nov;60(5):608-13. - PubMed
    1. Olsson G. Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial. Am Heart J. 1988 Jul;116(1 Pt 2):334-8. - PubMed
    1. Vedin A. Ten years of clinical experience with metoprolol. J Cardiovasc Pharmacol. 1987;10 Suppl 2:S80-5. - PubMed
    1. Prakash A, Markham A. Metoprolol: a review of its use in chronic heart failure. Drugs. 2000 Sep;60(3):647-78. - PubMed
    1. Hjalmarson A, Herlitz J, Holmberg S, Rydén L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation. 1983 Jun;67(6 Pt 2):I26-32. - PubMed

Publication types

LinkOut - more resources